Media ReleasesElixinol Global

View All Elixinol Global News


Elixinol Global - Appendix 3Y - Paul Benhaim


In accordance with ASX Listing Rule 3.19A.2, Elixinol Global Limited (Elixinol or the Company) provides an Appendix 3Y for Mr Paul Benhaim.

The Company refers to the market announcement on 17 June 2020 confirming that Raw with Life Pty Ltd (Raw with Life), a company controlled by Elixinol Global founder and Non-Executive Director, Mr Paul Benhaim entered into a margin loan facility (Loan Facility) with Equities First Holdings LLC (Equities First). To secure repayment of any loan under the Loan Facility, Mr Benhaim confirmed that he intended to transfer up to 17,000,000 fully paid ordinary shares in Elixinol (Secured Shares) to Equities First as security for loans under the Loan Facility. Mr Benhaim has now completed the second tranche of Secured Shares to Equities First, being 8,000,000 shares in Elixinol.

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.